NVTP NOVT Corporation featured news, full reports, and detailed charts
NOVT Corporation (NVTP/NVTP.PK) Wrap Up:
NOVT Corporation does not have significant operations. Prior to March 2006, the company engaged in developing therapeutic solutions for the prevention and treatment of vascular diseases. It commercialized the Beta-Cath System, an intraluminal beta radiation catheter delivery system designed to reduce restenosis subsequent to percutaneous transluminal coronary angioplasty. NOVT Corporation was co-founded by Thomas D. Weldon and Charles E. Larsen. The company was incorporated in 1987. It was formerly known as Novoste Corporation and changed its name to NOVT Corporation in 2006. The company is headquartered in San Jose, California.NOVT Corporation (NVTP:OTC)
|
Market Cap
8.2M
|
Total Revenue
--
|
|
|
EBITDA
--
|
DILUTED EPS TTM
-0.05
|
|
|
P/E
--
|
P/S
--
|
|
|
Return On Asset
-2.39
|
Return On Equity
-1.83
|
|
| K = Thousands M = Millions B = Billions | ||
NVTP Top Compensated Officers
Executives, Board Directors
Key developments for NOVT Corporation (NVTP)
NOVT Corporation reported unaudited consolidated earnings results for the third quarter and nine months ended Sept. 30, 2008. For the quarter, the company reported net income of $1,000 and loss from operations of $99,000 against net loss of $55,000 or $0.01 per basic and diluted share and loss from operations of $193,000 for the same period of last year. For the quarter, the company reported net loss of $7,000 and loss from operations of $318,000 against net loss of $151,000 or $0.04 per basic and diluted share and loss from operations of $521,000 for the same period of last year.
NOVT Corporation announced earnings results for the second quarter and six months ended June 30, 2008. For the quarter, the company has net loss of $14,000 or $0.00 basic and diluted net loss per share against net loss of $36,000 or $0.01 basic and diluted net loss per share reported a year ago. For the quarter, the company has loss from operations of $173,000 against loss from operations of $114,000 reported a year ago. For the six months, the company has net loss of $8,000 or $0.00 basic and diluted net loss per share against net loss of $96,000 or $0.02 basic and diluted net loss per share reported a year ago. For the quarter, the company has loss from operations of $220,000 against loss from operations of $329,000 reported a year ago.
NOVT Corporation, Annual General Meeting, Nov 03, 2008, at 14:00 US Eastern Time. Location: Olshan Grundman Frome Rosenzweig & Wolosky LLP, Park Avenue Tower, 65 East 55th Street, 2nd Floor, New York, NY 10022,United States. Agenda: To elect three directors to Board of Directors to serve until 2009 annual meeting of shareholders and until their successors are elected and qualified; to ratify the appointment of Tauber & Balser, P.C. as independent accountants for the fiscal year ending December 31, 2008 and to transact any other matters that may properly come before the Meeting and any adjournment or postponement thereof.
NVTP Competitors
| Company | Last | Change | |
| No competitor information is available for NVTP. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | NVTP | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | 0.6x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
|
NVTP |
||
NVTP transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
